A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer
Clinical trial NCT06340165 · UNKNOWN
Trial details
- NCT number
- NCT06340165
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-04
- Primary completion
- 2025-06-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.